Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15M Sell
49,670
-15,610
-24% -$3.1M 1.48% 14
2026
Q1
$9.61M Sell
65,280
-31,840
-33% -$4.66M 1.1% 25
2025
Q4
$11.8M Sell
97,120
-27,130
-22% -$3.18M 1.37% 17
2025
Q3
$13.4M Buy
124,250
+17,350
+16% +$1.62M 1.56% 12
2025
Q2
$9.58M Buy
+106,900
New +$8.04M 1.22% 20
2024
Q2
Sell
-23,110
Closed -$1.71M 297
2024
Q1
$1.61M Buy
+23,110
New +$1.48M 0.21% 124
2023
Q4
Sell
-60,710
Closed -$3.16M 290
2023
Q3
$2.78M Sell
60,710
-18,940
-24% -$908K 0.44% 73
2023
Q2
$3.86M Buy
+79,650
New +$3.33M 0.57% 57

Other funds holding KLAC

Genus Capital Management's KLAC Position: Q2 2026 in Review

Genus Capital Management reduced its KLA (KLAC) stake by 24% in Q2 2026, selling an estimated $3.1M and leaving 49,670 shares worth $15M. The position accounts for 1.48% of the portfolio, ranked #14.

Genus Capital Management first reported a position in KLAC in Q2 2023 and has held it in 8 quarters since. 2,474 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • Genus Capital Management held 49,670 shares of KLA worth $15M as of Q2 2026.
  • Genus Capital Management sold 15,610 KLA shares in Q2 2026, an estimated $3.1M.
  • KLA made up 1.48% of Genus Capital Management's portfolio in Q2 2026, its #14 holding.
  • Genus Capital Management first reported a position in KLA in Q2 2023 and has held it in 8 quarters since.
  • 2,474 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.